Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

707 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Totality outcome of afatinib sequential treatment in patients with EGFR mutation-positive non-small cell lung cancer in South Korea (TOAST): Korean Cancer Study Group (KCSG) LU-19-22.
Jung HA, Hong MH, Lee HW, Lee KH, Kim IH, Min YJ, Ahn HK, Shim BY, Choi YH, Lee YG, Kim JA, Jang JS, Shin SH, Park KU, Kang JH, Park K. Jung HA, et al. Among authors: lee kh, lee hw, lee yg. Transl Lung Cancer Res. 2022 Jul;11(7):1369-1379. doi: 10.21037/tlcr-22-79. Transl Lung Cancer Res. 2022. PMID: 35958320 Free PMC article.
Open-Label, Multicenter, Phase II Study of Ceritinib in Patients With Non-Small-Cell Lung Cancer Harboring ROS1 Rearrangement.
Lim SM, Kim HR, Lee JS, Lee KH, Lee YG, Min YJ, Cho EK, Lee SS, Kim BS, Choi MY, Shim HS, Chung JH, La Choi Y, Lee MJ, Kim M, Kim JH, Ali SM, Ahn MJ, Cho BC. Lim SM, et al. Among authors: lee js, lee kh, lee mj, lee yg, lee ss. J Clin Oncol. 2017 Aug 10;35(23):2613-2618. doi: 10.1200/JCO.2016.71.3701. Epub 2017 May 18. J Clin Oncol. 2017. PMID: 28520527 Clinical Trial.
Antiemetic Corticosteroid Rotation from Dexamethasone to Methylprednisolone to Prevent Dexamethasone-Induced Hiccup in Cancer Patients Treated with Chemotherapy: A Randomized, Single-Blind, Crossover Phase III Trial.
Go SI, Koo DH, Kim ST, Song HN, Kim RB, Jang JS, Oh SY, Lee KH, Lee SI, Kim SG, Park LC, Lee SC, Park BB, Ji JH, Yi SY, Lee YG, Yun J, Bruera E, Hwang IG, Kang JH. Go SI, et al. Among authors: lee si, lee kh, lee yg, lee sc. Oncologist. 2017 Nov;22(11):1354-1361. doi: 10.1634/theoncologist.2017-0129. Epub 2017 Jul 7. Oncologist. 2017. PMID: 28687626 Free PMC article. Clinical Trial.
Predicting cumulative incidence of adverse events in older patients with cancer undergoing first-line palliative chemotherapy: Korean Cancer Study Group (KCSG) multicentre prospective study.
Kim JW, Lee YG, Hwang IG, Song HS, Koh SJ, Ko YH, Shin SH, Woo IS, Hong S, Kim TY, Kim SY, Nam BH, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Bae SH, Koo DH, Kim KI, Kim JH. Kim JW, et al. Among authors: lee ma, lee yg. Br J Cancer. 2018 May;118(9):1169-1175. doi: 10.1038/s41416-018-0037-6. Epub 2018 Mar 26. Br J Cancer. 2018. PMID: 29576622 Free PMC article. Clinical Trial.
Prospective Validation of The Korean Cancer Study Group Geriatric Score (KG)-7, a Novel Geriatric Screening Tool, in Older Patients with Advanced Cancer Undergoing First-line Palliative Chemotherapy.
Kim JW, Kim SH, Lee YG, Hwang IG, Kim JY, Koh SJ, Ko YH, Shin SH, Woo IS, Hong S, Kim TY, Baek JY, Kim HJ, Kim HJ, Lee MA, Kwon JH, Hong YS, Ryoo HM, Lee KH, Kim JH. Kim JW, et al. Among authors: lee ma, lee kh, lee yg. Cancer Res Treat. 2019 Jul;51(3):1249-1256. doi: 10.4143/crt.2018.451. Epub 2019 Jan 2. Cancer Res Treat. 2019. PMID: 30653746 Free PMC article.
Lazertinib in patients with EGFR mutation-positive advanced non-small-cell lung cancer: results from the dose escalation and dose expansion parts of a first-in-human, open-label, multicentre, phase 1-2 study.
Ahn MJ, Han JY, Lee KH, Kim SW, Kim DW, Lee YG, Cho EK, Kim JH, Lee GW, Lee JS, Min YJ, Kim JS, Lee SS, Kim HR, Hong MH, Ahn JS, Sun JM, Kim HT, Lee DH, Kim S, Cho BC. Ahn MJ, et al. Among authors: lee dh, lee js, lee kh, lee yg, lee gw, lee ss. Lancet Oncol. 2019 Dec;20(12):1681-1690. doi: 10.1016/S1470-2045(19)30504-2. Epub 2019 Oct 3. Lancet Oncol. 2019. PMID: 31587882 Clinical Trial.
Interference with daily functioning by breakthrough pain in patients with cancer.
Kang JH, Koh SJ, Oh SY, Kim RB, Shin SH, Lee YG, Kim BS, Ryoo HM, Yoon SY, Jang JS, Oh HS, Choi YJ, Lee MH, Lee KH. Kang JH, et al. Among authors: lee mh, lee kh, lee yg. Support Care Cancer. 2020 Nov;28(11):5177-5183. doi: 10.1007/s00520-020-05329-9. Epub 2020 Feb 14. Support Care Cancer. 2020. PMID: 32056013
Ramosetron versus Palonosetron in Combination with Aprepitant and Dexamethasone for the Control of Highly-Emetogenic Chemotherapy-Induced Nausea and Vomiting.
Kang JH, Kwon JH, Lee YG, Park KU, An HJ, Sohn J, Seol YM, Lee H, Yun HJ, Ahn JS, Yang JH, Song H, Koo DH, Kim JY, Kim GM, Kim HJ. Kang JH, et al. Among authors: lee h, lee yg. Cancer Res Treat. 2020 Jul;52(3):907-916. doi: 10.4143/crt.2019.713. Epub 2020 Mar 18. Cancer Res Treat. 2020. PMID: 32192275 Free PMC article. Clinical Trial.
Prognostic Value of CD200R1 mRNA Expression in Head and Neck Squamous Cell Carcinoma.
Chang H, Lee YG, Ko YH, Cho JH, Choi JK, Park KU, Kang EJ, Lee KW, Lim SM, Kim JS, Lee HW, Kim MK, Hwang IG, Kim S, Nam BH, Kim HR. Chang H, et al. Among authors: lee kw, lee hw, lee yg. Cancers (Basel). 2020 Jul 3;12(7):1777. doi: 10.3390/cancers12071777. Cancers (Basel). 2020. PMID: 32635224 Free PMC article.
707 results